124 related articles for article (PubMed ID: 38293147)
1. E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer.
Patterson MR; Meijers AS; Ryder EL; Scarth JA; Evans D; Turner AL; Wasson CW; Darell JE; Theobald D; Cogan J; James CD; Wang M; Ladbury JE; Morgan IM; Samson A; Morgan EL; Macdonald A
bioRxiv; 2024 Jan; ():. PubMed ID: 38293147
[TBL] [Abstract][Full Text] [Related]
2. E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer.
Patterson MR; Meijers AS; Ryder EL; Wootton LM; Scarth JA; Evans D; Turner AL; Wasson CW; Darell JE; Theobald DA; Cogan JA; James CD; Wang M; Ladbury JE; Morgan IM; Samson A; Morgan EL; Macdonald A
Oncogene; 2024 May; ():. PubMed ID: 38789663
[TBL] [Abstract][Full Text] [Related]
3. E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer.
Morgan EL; Scarth JA; Patterson MR; Wasson CW; Hemingway GC; Barba-Moreno D; Macdonald A
Cell Death Differ; 2021 May; 28(5):1669-1687. PubMed ID: 33303976
[TBL] [Abstract][Full Text] [Related]
4. CREB1 activation promotes human papillomavirus oncogene expression and cervical cancer cell transformation.
Li Y; Patterson MR; Morgan EL; Wasson CW; Ryder EL; Barba-Moreno D; Scarth JA; Wang M; Macdonald A
J Med Virol; 2023 Aug; 95(8):e29025. PubMed ID: 37565725
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
[TBL] [Abstract][Full Text] [Related]
6. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
Harden ME; Prasad N; Griffiths A; Munger K
mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
[TBL] [Abstract][Full Text] [Related]
7. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
8. Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling.
Bossler F; Kuhn BJ; Günther T; Kraemer SJ; Khalkar P; Adrian S; Lohrey C; Holzer A; Shimobayashi M; Dürst M; Mayer A; Rösl F; Grundhoff A; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F
mBio; 2019 Feb; 10(1):. PubMed ID: 30755508
[TBL] [Abstract][Full Text] [Related]
9. Exploitation of ATP-sensitive potassium ion (K
Scarth JA; Wasson CW; Patterson MR; Evans D; Barba-Moreno D; Carden H; Cassidy R; Whitehouse A; Mankouri J; Samson A; Morgan EL; Macdonald A
Oncogene; 2023 Aug; 42(34):2558-2577. PubMed ID: 37443304
[TBL] [Abstract][Full Text] [Related]
10. Effects of Metformin on the virus/host cell crosstalk in human papillomavirus-positive cancer cells.
Hoppe-Seyler K; Herrmann AL; Däschle A; Kuhn BJ; Strobel TD; Lohrey C; Bulkescher J; Krijgsveld J; Hoppe-Seyler F
Int J Cancer; 2021 Sep; 149(5):1137-1149. PubMed ID: 33844847
[TBL] [Abstract][Full Text] [Related]
11. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.
Honegger A; Schilling D; Bastian S; Sponagel J; Kuryshev V; Sültmann H; Scheffner M; Hoppe-Seyler K; Hoppe-Seyler F
PLoS Pathog; 2015 Mar; 11(3):e1004712. PubMed ID: 25760330
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
[TBL] [Abstract][Full Text] [Related]
13. HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys.
Peta E; Sinigaglia A; Masi G; Di Camillo B; Grassi A; Trevisan M; Messa L; Loregian A; Manfrin E; Brunelli M; Martignoni G; Palù G; Barzon L
Oncogene; 2018 Mar; 37(12):1654-1668. PubMed ID: 29335520
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
Bellone S; El-Sahwi K; Cocco E; Casagrande F; Cargnelutti M; Palmieri M; Bignotti E; Romani C; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
J Virol; 2009 Jul; 83(13):6779-89. PubMed ID: 19386711
[TBL] [Abstract][Full Text] [Related]
15. Repression of Memo1, a Novel Target of Human Papillomavirus Type 16 E7, Increases Cell Proliferation in Cervical Cancer Cells.
Trejo-Cerro O; Massimi P; Broniarczyk J; Myers M; Banks L
J Virol; 2022 Oct; 96(20):e0122922. PubMed ID: 36197110
[TBL] [Abstract][Full Text] [Related]
16. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
17. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells.
Zhang X; Zhang A; Zhang X; Hu S; Bao Z; Zhang Y; Jiang X; He H; Zhang TC
Virus Res; 2021 Dec; 306():198602. PubMed ID: 34662680
[TBL] [Abstract][Full Text] [Related]
18. HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer.
Yu L; Majerciak V; Lobanov A; Mirza S; Band V; Liu H; Cam M; Hughes SH; Lowy DR; Zheng Z-M
mBio; 2024 May; 15(5):e0072924. PubMed ID: 38624210
[TBL] [Abstract][Full Text] [Related]
19. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
20. miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway.
Leung CO; Deng W; Ye TM; Ngan HY; Tsao SW; Cheung AN; Pang RT; Yeung WS
Carcinogenesis; 2014 Sep; 35(9):1931-40. PubMed ID: 24503442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
